Clinical trials
Not yet recruiting Diabetes Mellitus, Type 2 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 4 |
| 2025 | 10 |
| 2026 | 27 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 43 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fujian Shengdi Pharmaceutical Co., Ltd. | 3 |
| Gan & Lee Pharmaceuticals. | 2 |
| Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2 |
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2 |
| Jiangxi University of Traditional Chinese Medicine | 2 |
| Yanbing Li | 2 |
| Beijing Chao Yang Hospital | 1 |
| CSPC Ouyi Pharmaceutical Co., Ltd. | 1 |
| Chendu DIAO Pharmaceutical Group CO., LTD. | 1 |
| Duke Kunshan University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 43 |
| Obesity | 4 |
| Diabetes Mellitus | 2 |
| Diabetic Nephropathies | 2 |
| Insulin Resistance | 2 |
| Overweight | 2 |
| Prediabetic State | 2 |
| Renal Insufficiency, Chronic | 2 |
| Albuminuria | 1 |
| Cardiovascular Diseases | 1 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.